US Patent Issued to London Pharmaceuticals and Research on June 16 for "Cannabinoid sulfate esters, their salts and uses thereof" (Canadian Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,094, issued on June 16, was assigned to London Pharmaceuticals and Research Corp. (London, Canada).

"Cannabinoid sulfate esters, their salts and uses thereof" was invented by Mahmoud Mohamed Abdrabo Moustafa (London, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Cannabinoid sulfate esters, their soluble salts and stable formulations thereof, as well as their edible, beverage and medicinal applications. The cannabinoid sulfate ester salts may be used as drugs or prodrugs for treating various conditions related to the modulation or biased modulation of cannabinoid receptors, including but not limited to, pain and inflammation, cancer, glaucoma...